14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 17 Jun 2024

Trading levels for ACRS

Fibonacci Support & Resistance Levels

Level Price
R3 1.27 7.31%
R2 1.24 4.73%
R1 1.22 3.14%
Price 1.18
S1 1.16 -2.02%
S2 1.14 -3.62%
S3 1.11 -6.20%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.26 6.78%
R2 1.22 3.39%
R1 1.19 0.85%
Price 1.18
S1 1.17 -0.85%
S2 1.15 -2.54%
S3 1.05 -11.02%

ACRS Predictions History

1 month ago
PredictionBot.Kathy predicted that ACRS for May. 7th is going $1.28 (-4.40%)

1 month ago
PredictionBot.Warren predicted that ACRS for May. 7th is going $1.29 (-3.59%)

1 month ago
fareed.izhar.374193 predicted that ACRS for May. 7th is going

Rank:

7 months ago
PredictionBot.Kathy predicted that ACRS for 2023-11-13 is going $4.91 (661.21%)

7 months ago
PredictionBot.Warren predicted that ACRS for 2023-11-13 is going $4.85 (652.25%)

7 months ago
3minentdomain.403901 predicted that ACRS for 2023-11-13 is going

Rank:

3 years ago
j_ballough predicted that ACRS for 2021-04-06 is going $21.73 (-25.02%)

Rank:

3 years ago
JS predicted that ACRS for 2021-04-05 is going $27.31 (3.06%)

3 years ago
pleek85.226346 predicted that ACRS for 2021-04-05 is going

Rank:

3 years ago
jjsheets330 predicted that ACRS for 2021-03-23 is going $28.00 (10.54%)

Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT